These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6654527)

  • 1. Effects on metastases of drug therapy during developing and established tumor immunity.
    Vaage J; Costanza ME
    Int J Cancer; 1983 Dec; 32(6):759-63. PubMed ID: 6654527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma.
    Vaage J; Costanza ME
    Cancer Res; 1979 Nov; 39(11):4466-71. PubMed ID: 498077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sequence of administration of methotrexate, leucovorin, and 5-fluorouracil on mammary tumor growth and survival in syngeneic C3H mice.
    Heppner GH; Calabresi P
    Cancer Res; 1977 Dec; 37(12):4580-3. PubMed ID: 303542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of viral glycoprotein reflect enhanced effectiveness of combined drug treatments.
    Ritzi EM; Pyo S
    Life Sci; 1994; 54(13):887-99. PubMed ID: 8139377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental toxicologic and therapeutic studies on the activity of the CMF(cyclophosphamide-methotrexate-5-fluorouracil) scheme versus the VMF(vincristine-methotrexate-5-fluorouracil) scheme].
    Berger MR; Habs M; Schmähl D
    Arch Geschwulstforsch; 1984; 54(4):263-78. PubMed ID: 6548622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantable mouse mammary adenocarcinoma 16/c as a model in experimental cancer therapy. III. Sensitivity to antitumor drugs.
    Rak J; Kuśnierczyk H; Strzadała L; Kłosiewicz S; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):389-97. PubMed ID: 2639635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
    Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic consequences of antitumour drug interactions: methotrexate and 5-fluorouracil in the chemotherapy of C3H mice with transplanted mammary adenocarcinoma.
    Brown I; Ward HW
    Cancer Lett; 1978 Nov; 5(5):291-7. PubMed ID: 728887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing transplantation characteristics with serial in vivo passage of C3H/He mammary carcinomas.
    Vaage J
    Cancer Res; 1978 Oct; 38(10):3264-8. PubMed ID: 688216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K; Tanaka T; Takeuchi M
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complete regression of breast cancer and its lung metastases after chemohormonotherapy].
    Borisov VI; Vorob'ev AN; Stsetsevich NV; Ass NIa
    Sov Med; 1986; (12):123-4. PubMed ID: 3563699
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical application of the concept of methotrexate plus 5-FU sequence-dependent "synergy": how good is the evidence?
    Browman GP
    Cancer Treat Rep; 1984 Mar; 68(3):465-9. PubMed ID: 6200218
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy of WAP-T mouse mammary carcinomas aggravates tumor phenotype and enhances tumor cell dissemination.
    Jannasch K; Wegwitz F; Lenfert E; Maenz C; Deppert W; Alves F
    Int J Cancer; 2015 Jul; 137(1):25-36. PubMed ID: 25449528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of metastasized breast cancer].
    Thurm K
    Z Erkr Atmungsorgane; 1986; 166(1):112-5. PubMed ID: 3953107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preclinical and clinical studies of sequential therapy with methotrexate and 5 fluorouracil in breast cancer].
    Kitamura M; Tominaga T; Hayashi K; Takahashi I; Kosaki G
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2430-8. PubMed ID: 3572145
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.
    Grau C; Overgaard J
    Cancer Chemother Pharmacol; 1992; 30(4):277-80. PubMed ID: 1643695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
    Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
    Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adriablastin (doxorubicin) in the combined chemotherapy of patients with disseminated forms of breast cancer].
    Voznyĭ EK; Besova NS; Kurkina TV; Al'tshtuller IuB
    Antibiotiki; 1984 Jun; 29(6):463-8. PubMed ID: 6476811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
    Wietrzyk J; Opolski A; Madej J; Radzikowski C
    Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.
    Heppner GH; Dexter DL; DeNucci T; Miller FR; Calabresi P
    Cancer Res; 1978 Nov; 38(11 Pt 1):3758-63. PubMed ID: 698935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.